anmelden
SPI
20.270,57
PKT
+7,35
PKT
+0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.06.12 | Julius Bär buy | UBS AG | |
| 12.06.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 12.06.12 | Swiss Life buy | Nomura | |
| 12.06.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 12.06.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 12.06.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 11.06.12 | Nestlé hold | Société Générale Group S.A. (SG) | |
| 11.06.12 | UBS hold | Commerzbank Corp. & Markets | |
| 11.06.12 | Barry Callebaut neutral | Sarasin Research | |
| 11.06.12 | Roche neutral | J.P. Morgan Cazenove | |
| 11.06.12 | Roche neutral | Nomura | |
| 11.06.12 | Barry Callebaut hold | Vontobel Research | |
| 11.06.12 | Novartis hold | Vontobel Research | |
| 08.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 08.06.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 08.06.12 | UBS buy | WestLB AG | |
| 08.06.12 | Logitech neutral | Sarasin Research | |
| 08.06.12 | EFG International reduce | Sarasin Research | |
| 08.06.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 08.06.12 | Logitech hold | Vontobel Research | |
| 08.06.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 07.06.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 07.06.12 | Roche buy | Société Générale Group S.A. (SG) | |
| 07.06.12 | Avolta (ex Dufry) hold | Vontobel Research | |
| 07.06.12 | LEM hold | Vontobel Research | |
| 06.06.12 | Holcim neutral | Goldman Sachs Group Inc. | |
| 06.06.12 | Holcim sell | Goldman Sachs Group Inc. | |
| 06.06.12 | LEM hold | Vontobel Research | |
| 06.06.12 | Geberit hold | Vontobel Research | |
| 06.06.12 | Burckhardt Compression hold | Vontobel Research | |
| 06.06.12 | ARYZTA buy | Vontobel Research | |
| 06.06.12 | Ypsomed hold | Vontobel Research | |
| 06.06.12 | OC Oerlikon buy | Vontobel Research | |
| 05.06.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 05.06.12 | Roche outperform | Exane-BNP Paribas SA | |
| 05.06.12 | ARYZTA neutral | Sarasin Research | |
| 05.06.12 | ARYZTA buy | Vontobel Research | |
| 05.06.12 | Novartis hold | Vontobel Research | |
| 04.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 04.06.12 | Roche neutral | Citigroup Corp. |
